60 Degrees Pharmaceuticals

60 Degrees Pharmaceuticals is a growth-oriented specialty pharmaceutical company aimed at leveraging cutting-edge biosciences and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. The company has successfully obtained regulatory approval for Arakoda, a malaria prevention therapy launched at the end of 2019. Currently, 60P’s development pipeline includes projects targeting COVID-19, fungal infections, tick-borne diseases, and other viral diseases through Arakoda and Selgocivir.